Amygdalin prevents multidrug-resistant Staphylococcus aureus-induced lung epithelial cell injury by regulating inflammation and oxidative stress
Open Access
- 16 September 2024
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (9) , e0310253
Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) is an opportunistic pathogen that can cause severe bacterial pneumonia. Amygdalin is the main active pharmaceutical ingredient of bitter almond, which has broad-spectrum antibacterial, anti-inflammatory, anti-oxidation and immunomodulatory effects. It is also the main ingredient of Yinhua Pinggan granule, which is commonly used to moisten the lung and relieve cough. However, little is known about the effects of amygdalin on MRSA. In this study, we found that amygdalin exhibited good antimicrobial activity in vitro against MRSA. Amygdalin has a protective effect on MRSA infected cells, and the effect is better when combined with levofloxacin. It also can reduce the adhesion and invasion of MRSA to cells. Amygdalin has anti-inflammatory and antioxidant effects, which can significantly reduce the increase of inflammatory factors and the production of ROS caused by infection. The protective mechanism of amygdalin on cells may be related to inhibiting the expression of NLRP3, ASC and IL-1β pyroptosis pathways. Taken together, our study suggests that amygdalin exerts antibacterial effects by affecting biofilm formation, the expression of virulence factors, and drug resistance genes. Amygdalin combined with levofloxacin has a protective effect on A549 cells infected with MRSA, and the mechanism may be related to the inhibition of inflammatory response, oxidative damage and pyroptosis.Keywords
Funding Information
- National Natural Science Foundation of China (81930111)
This publication has 42 references indexed in Scilit:
- Investigation of Staphylococcus aureus Adhesion and Invasion of Host Cells2013
- Staphylococcus aureus α-Toxin: Nearly a Century of IntrigueToxins, 2013
- Inhibitory effects of simvastatin on staphylococcus aureus lipoteichoic acid-induced inflammation in human alveolar macrophagesClinical and Experimental Medicine, 2013
- Staphylococcal Infections: Mechanisms of Biofilm Maturation and Detachment as Critical Determinants of PathogenicityAnnual Review of Medicine, 2013
- Pharmacotherapy for Methicillin-Resistant Staphylococcus aureus Nosocomial PneumoniaAnnals of Pharmacotherapy, 2012
- Modulation of Inflammasome Pathways by Bacterial and Viral PathogensThe Journal of Immunology, 2011
- Nontoxigenic protein A vaccine for methicillin-resistant Staphylococcus aureus infections in miceJournal of Experimental Medicine, 2010
- Prevention and Treatment ofStaphylococcus aureusPneumonia with a β-Cyclodextrin DerivativeAntimicrobial Agents and Chemotherapy, 2010
- Staphylococcus aureus α-Hemolysin Activates the NLRP3-Inflammasome in Human and Mouse Monocytic CellsPLOS ONE, 2009
- Mechanisms of Antibiotic Resistance in Staphylococcus AureusFuture Microbiology, 2007